TP53 and breast carcinoma: In Latin America, the PRECAMA study (Molecular Subtypes of Premenopausal Breast Cancer in Latin American Women) identified the highest frequency of mutations in TP53, PIK3CA, and AKT1 (32.5%, 21.4%, and 9.5%, respectively) [9].